Sign in
FEMY Stock Price, Chart, Stats & News
Femasys Inc.
Save
Femasys Inc. (FEMY) does not currently pay a dividend.
9.21M
Market cap
–
Current P/E
–
Forward P/E
FEMY chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 42.39% |
Operating margin | -858.04% |
Pretax margin | -960.23% |
Net margin | -960.53% |
Effective tax rate | -0.03% |
ROA | -121.55% |
ROE | -764.17% |
D/E | 1.85x |
Interest coverage ratio | -9.20x |
FEMY valuation
P/E | – |
P/S | 6.89x |
P/B | 3.06x |
P/CF | -0.71x |
P/FCF | -0.71x |
P/OCF | -0.71x |
PEG | -0.04x |
EV multiple | -0.61x |
About
Femasys Inc., a biomedical company established in 2004 and based in Suwanee, Georgia, primarily targets the women's healthcare market within the United States. The firm's innovative product line includes permanent contraceptive solutions such as FemBloc and FemChec, alongside FemaSeed, which is an artificial insemination offering. For diagnostic purposes, Femasys provides FemCerv, a biopsy device utilized for endocervical curettage, and FemEMB, a product candidate intended for endometrial sampling to assist in the detection of uterine cancer.
Similar securities
Based on sector and market capitalization
Report issue